Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025- Product Image Royalty Rates in Pharmaceutical and Biotechnology Deals · GlobeNewswire Inc. Royalty Rates in Pharmaceutical and ...

Eli Lilly LLY announced that it has entered into a definitive agreement to acquire U.K.-based Centessa Pharmaceuticals CNTA.

US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug discovery, highlighting ...

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for ...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin ...

Biotech companies are all about innovation. These players are developing and using cutting-edge technologies to address a variety of diseases, and in many cases, their efforts are leading to ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Catalyst Pharmaceuticals saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.